Bringing unparalleled accuracy into clinical trial design and execution.

TrialKey is an AI-based clinical trial predictor with an accuracy rate of +90%– the highest in the market to date. The platform provides users access to tailored, actionable steps to address critical trial challenges, improving the likelihood of success as quickly as possible and at lower costs.

By harnessing the power of AI we deliver customized recommendations that help streamline trial design and execution.

Our core purpose is to accelerate and empower more efficient clinical trial processes, ultimately leading to significant medical research advancements for the benefit of all.

Mission

Our mission is to make a meaningful difference in medicine by leveraging AI to refine recommendations, optimise trial designs, and pioneer innovative solutions that address broader medical challenges.

Vision

To be positioned as the gold standard platform for clinical trial design optimisation and prediction worldwide.

Our Leadership Team

With decades of relevant experience, we have industry veterans at the helm.

THEO VORONOV
THEO VORONOV PARTNER — ADVANTAGE DATA
DR EUGENE DUBBOSARKYK
DR EUGENE DUBBOSARKYK PARTNER — ADVANTAGE DATA

Accuracy in clinical trials starts here.

TrialKey stands as the market leader for clinical trial prediction and design optimization, with an accuracy rate of +90%